A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 5,816 shares of EW stock, worth $435,094. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,816
Previous 3,784 53.7%
Holding current value
$435,094
Previous $350,000 9.71%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$59.7 - $93.78 $121,310 - $190,560
2,032 Added 53.7%
5,816 $384,000
Q2 2024

Jul 22, 2024

BUY
$84.3 - $94.31 $66,765 - $74,693
792 Added 26.47%
3,784 $350,000
Q1 2024

Apr 30, 2024

SELL
$72.54 - $95.56 $2,321 - $3,057
-32 Reduced 1.06%
2,992 $286,000
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $33,199 - $41,834
-538 Reduced 15.1%
3,024 $231,000
Q3 2023

Oct 30, 2023

BUY
$69.28 - $93.38 $104,612 - $141,003
1,510 Added 73.59%
3,562 $247,000
Q2 2023

Jul 17, 2023

BUY
$81.41 - $94.33 $132,047 - $153,003
1,622 Added 377.21%
2,052 $194,000
Q1 2022

May 03, 2022

SELL
$101.96 - $128.34 $1.49 Million - $1.88 Million
-14,620 Reduced 97.14%
430 $51,000
Q4 2021

Feb 07, 2022

BUY
$106.37 - $130.68 $1.54 Million - $1.89 Million
14,500 Added 2636.36%
15,050 $1.96 Million
Q3 2021

Oct 25, 2021

SELL
$102.91 - $122.75 $142,839 - $170,377
-1,388 Reduced 71.62%
550 $62,000
Q2 2021

Jul 26, 2021

SELL
$83.84 - $104.76 $57,178 - $71,446
-682 Reduced 26.03%
1,938 $654,000
Q1 2021

Apr 27, 2021

BUY
$78.68 - $90.67 $17,466 - $20,128
222 Added 9.26%
2,620 $732,000
Q4 2020

Jan 26, 2021

BUY
$71.69 - $91.23 $39,429 - $50,176
550 Added 29.76%
2,398 $704,000
Q3 2020

Oct 20, 2020

BUY
$67.19 - $87.44 $94,066 - $122,416
1,400 Added 312.5%
1,848 $148,000
Q2 2020

Jul 14, 2020

BUY
$57.54 - $76.95 $25,777 - $34,473
448 New
448 $31,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.